Study of Safety and Efficacy of Iberdomide (CC-220) and CC-99282 Combined With R-CHOP to Treat Lymphoma
Celgene
Celgene
AstraZeneca
Regeneron Pharmaceuticals
University of Birmingham
National Institutes of Health Clinical Center (CC)
H. Lee Moffitt Cancer Center and Research Institute
Canadian Cancer Trials Group
University of Washington
The First Affiliated Hospital of Soochow University
Shanghai Junshi Bioscience Co., Ltd.
Imbioray (Hangzhou) Biomedicine Co., Ltd.
Columbia University
Guangzhou Lupeng Pharmaceutical Company LTD.